Brad Roberts - LifeMD Chief Officer
| LFMD Stock | USD 6.47 0.67 11.55% |
Insider
Brad Roberts is Chief Officer of LifeMD Inc
| Age | 43 |
| Address | 236 Fifth Avenue, New York, NY, United States, 10001 |
| Phone | 866 351 5907 |
| Web | https://lifemd.com |
LifeMD Management Efficiency
The company has return on total asset (ROA) of (0.2134) % which means that it has lost $0.2134 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.8248) %, meaning that it created substantial loss on money invested by shareholders. LifeMD's management efficiency ratios could be used to measure how well LifeMD manages its routine affairs as well as how well it operates its assets and liabilities. As of November 26, 2024, Return On Tangible Assets is expected to decline to -0.5. The current year's Return On Capital Employed is expected to grow to -0.58. At present, LifeMD's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 44.7 M, whereas Net Tangible Assets are projected to grow to (16.7 M).Similar Executives
| Showing other executives | INSIDER Age | ||
| CPA CPA | National Research Corp | 66 | |
| Teresa McMeans | CareMax | N/A | |
| M Duffy | Evolent Health | 61 | |
| Jacob Goldberger | Streamline Health Solutions | N/A | |
| Amy Sebero | Streamline Health Solutions | N/A | |
| Jim MD | Privia Health Group | N/A | |
| Jon Boumstein | National Research Corp | N/A | |
| Andrew Douglas | Forian Inc | N/A | |
| Donald Vick | Streamline Health Solutions | 60 | |
| MB CCS | Streamline Health Solutions | N/A | |
| Matthew Morris | Privia Health Group | 60 | |
| Mark Grove | Forian Inc | N/A | |
| Helen Hrdy | National Research Corp | 59 | |
| Daniel Barton | Forian Inc | 59 | |
| Jawad Shaikh | Streamline Health Solutions | N/A | |
| Wendy Lucio | Streamline Health Solutions | N/A | |
| Kali Beyah | Evolent Health | N/A | |
| Jessica Somers | Evolent Health | N/A | |
| Adam Dublin | Forian Inc | 58 | |
| Niberto MD | CareMax | N/A | |
| Tunde Sotunde | Evolent Health | N/A | |
Management Performance
| Return On Equity | -7.82 | ||||
| Return On Asset | -0.21 |
LifeMD Inc Leadership Team
Elected by the shareholders, the LifeMD's board of directors comprises two types of representatives: LifeMD inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LifeMD. The board's role is to monitor LifeMD's management team and ensure that shareholders' interests are well served. LifeMD's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LifeMD's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alexander Mironov, President | ||
| Dennis Wijnker, Chief Officer | ||
| Tameca Brown, VP HR | ||
| Marc Benathen, Chief Officer | ||
| Varun Pathak, Chief Simpli | ||
| Shane Biffar, Chief Counsel | ||
| Jessica Friedeman, Chief Officer | ||
| Maria CPA, Controller Officer | ||
| Brad Roberts, Chief Officer | ||
| Justin Schreiber, Chairman CEO | ||
| Nicholas Alvarez, Chief Acquisition | ||
| Eric Yecies, General Officer | ||
| Stefan Galluppi, Chief Director |
LifeMD Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is LifeMD a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -7.82 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (0.12) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 238.77 M | ||||
| Shares Outstanding | 43.31 M | ||||
| Shares Owned By Insiders | 15.57 % | ||||
| Shares Owned By Institutions | 40.50 % | ||||
| Number Of Shares Shorted | 5.57 M | ||||
| Price To Book | 107.72 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.64) | Revenue Per Share 4.847 | Quarterly Revenue Growth 0.383 | Return On Assets (0.21) | Return On Equity (7.82) |
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.